S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

August 31, 2009

Conditions
Sarcoma
Interventions
PROCEDURE

conventional surgery

surgery

Trial Locations (23)

48073

William Beaumont Hospital - Royal Oak Campus, Royal Oak

72205

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock

75231

Presbyterian Hospital of Dallas, Dallas

80045

University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora

84112

Huntsman Cancer Institute at University of Utah, Salt Lake City

98104

Fred Hutchinson Cancer Research Center, Seattle

Harborview Medical Center, Seattle

Minor and James Medical, PLLC, Seattle

98112

Group Health Central Hospital, Seattle

98122

Polyclinic First Hill, Seattle

98225

St. Joseph Cancer Center, Bellingham

98273

Skagit Valley Hospital Cancer Care Center, Mount Vernon

98284

North Puget Oncology at United General Hospital, Sedro-Woolley

98310

Olympic Hematology and Oncology, Bremerton

99202

Cancer Care Northwest - Spokane South, Spokane

32610-0232

University of Florida Shands Cancer Center, Gainesville

48109-0942

University of Michigan Comprehensive Cancer Center, Ann Arbor

87131-5636

University of New Mexico Cancer Research and Treatment Center, Albuquerque

44309-2090

Akron City Hospital, Akron

97239-3098

Oregon Health & Science University Cancer Institute, Portland

98122-4307

Swedish Cancer Institute at Swedish Medical Center - First Hill Campus, Seattle

98195-6043

University Cancer Center at University of Washington Medical Center, Seattle

98801-2028

Wenatchee Valley Medical Center, Wenatchee

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

American College of Surgeons

OTHER

lead

SWOG Cancer Research Network

NETWORK

NCT00096213 - S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone | Biotech Hunter | Biotech Hunter